Picture of Sprint Bioscience AB logo

SPRINT Sprint Bioscience AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Sprint Bioscience Q4 Operating Loss Widens To SEK 10.8 Mln

Feb 20 (Reuters) - Sprint Bioscience AB  SPRINT.ST :
    * Q4 OPERATING RESULTS AT -10,8 (-7,2) MSEK
    * Q4 NET INCOME AT 0,2 (2,9) MSEK

Source text for Eikon:  ID:nWkr79sv4J 
Further company coverage:  SPRINT.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Sprint Bioscience AB

See all news